Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
暂无分享,去创建一个
H. Dombret | H. de Thé | A. Bazarbachi | O. Hermine | J. Poupon | B. Arnulf | G. Damaj | B. Varet | J. Brouet | L. Degos | R. Delarue | J. Fermand | P. Rousselot | F. Lefrère